MANNKIND CORP (MNKD)

US56400P7069 - Common Stock

3.78  +0.2 (+5.59%)

After market: 3.8706 +0.09 (+2.4%)

News Image
8 hours ago - Seeking Alpha

MannKind Non-GAAP EPS of $0.02 beats by $0.03, revenue of $58.47M beats by $5.33M (NASDAQ:MNKD)

MannKind Corporation's Q4 financial results exceeded expectations with non-GAAP EPS of $0.02, beating estimates by $0.03, and revenue of $58.47M, surpassing...

News Image
8 days ago - MannKind

MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2023 fourth quarter...

News Image
13 days ago - MannKind

MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®

MANNKIND ANNOUNCES ENROLLMENT GOAL COMPLETION OF INHALE-1 PEDIATRIC DIABETES TRIAL UTILIZING AFREZZA...

News Image
a month ago - InvestorPlace

3 Biotech Stocks to Sell in January Before They Crash and Burn

The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.

News Image
2 months ago - Seeking Alpha

KNDI, IREN and om are among after hour movers (NASDAQ:MNKD)

Gainers: MannKind Corporation (NASDAQ:MNKD) +5%.Kandi Technologies Group (KNDI) +5%.Outset Medical (OM) +4%.HWH International (HWH) +3%.Atea Pharmaceuticals...

News Image
2 months ago - Market News Video

Notable Tuesday Option Activity: SMCI, MRK, MNKD

News Image
2 months ago - Seeking Alpha

MannKind, Sagard Healthcare enter $200M royalty purchase deal (NASDAQ:MNKD)

MannKind (MNKD) sells a 1% royalty in Tyvaso DPI net sales to Sagard Healthcare for up to $200M, receiving an upfront payment of $150M.

News Image
2 months ago - MannKind

MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million

Sagard Healthcare purchased a 1% royalty in Tyvaso DPI® net salesPurchase price of $150 million; additional potential milestone payment of up to $50...

News Image
2 months ago - MannKind

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development...

News Image
3 months ago - InvestorPlace

High-Yield Haven: 3 Dividend Stocks to Secure Now

These are three different dividend stocks that have a great dividend yield and offer a reliable source of income.

News Image
4 months ago - The Motley Fool

MannKind (MNKD) Q3 2023 Earnings Call Transcript

MNKD earnings call for the period ending September 30, 2023.

News Image
4 months ago - MannKind

MannKind Corporation Reports 2023 Third Quarter Financial Results

Conference Call to Begin Today at 5:00 p.m. (ET) 3Q 2023 Total revenues of $51M; +56% vs. 3Q 20223Q YTD 2023 Total revenues of $140M; +121% vs. 3Q YTD...

News Image
4 months ago - MannKind

MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2023 third quarter...

News Image
4 months ago - MannKind

MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent

Patent covers compositions of clofazimine, and methods for treating lung infectionsDevelopment of MNKD-101 (inhaled clofazimine) continues for the...

News Image
5 months ago - Market News Video

MannKind Becomes Oversold (MNKD)

News Image
6 months ago - InvestorPlace

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.

News Image
6 months ago - MannKind

MannKind Corporation Announces Participation at Upcoming Conferences

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...

News Image
6 months ago - Market News Video

MNKD Crosses Below Key Moving Average Level

News Image
7 months ago - InvestorPlace

3 Biotech Stocks to Sell in August Before They Crash and Burn

These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.